Johnson & Johnson
Score: Positive (91)
42 days at current score.
Upgraded from Neutral on October 26th 2017
- This company ranked positively in 3 out of 4 IHS Markit Categories and also compared to the Healthcare sector
- Perception of the company's creditworthiness is positive
- ETFs holding this stock are seeing positive inflows
- Bearish sentiment is low
Short interest | Positive
Short interest is extremely low for JNJ with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting JNJ.
ETF/Index ownership | Positive
ETF activity is positive. Over the last month, ETFs holding JNJ are favorable, with net inflows of $9.78 billion. Additionally, the rate of inflows is increasing.
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.
Credit default swap | Positive
The current level displays a positive indicator. JNJ credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness.
Please send all inquiries related to the report to email@example.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.